FDA Scrutiny of Promotion and Advertising Practices 2017

  • 28-29 Sep 2017
  • Philadelphia, PA, United States

Description

FDA Scrutiny of Promotion and Advertising Practices 2017 is a course that covers topics such as:

  • Intersecting federal requirements by the Department of Justice, the Federal Trade Commission, the Securities and Exchange Commission and the Consumer Product Safety Commission
  • How FDA faces constitutional constraints on enforcement decisions
  • Ways that a firm violates FDA requirements
  • How the FDA interprets advertising and promotion in principle and in fact
  • How sales and marketing departments play a central role, for better or worse
  • Advertising and promotional material based on interactive group hypotheticals
  • How the federal government holds executive management responsible for missteps in promotion and advertising practices

FDA Scrutiny of Promotion and Advertising Practices 2017 is intended for:

  • Regulatory Managers
  • Sales and Marketing executives and managers
  • 3rtd party consultants
  • In-house Legal Counsel and Contract Specialists
  • Investors
  • Venture Capitalists
  • Owners of New or Developing Firms
  • Business Acquisition Executives
  • International Trade Managers
  • Own label distributors
  • Product specification developers

Past Events

Important

Please, check "FDA Scrutiny of Promotion and Advertising Practices" official website for possible changes, before making any traveling arrangements

Event Categories

Business: Internal Audit & Compliance, Legal, Management, Marketing & Sales, Quality assurance
Government & Global Issues: Law & Regulations
Science: Life Sciences & Biology

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions